Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome
- PMID: 27317957
- PMCID: PMC4913131
- DOI: 10.1016/j.hpb.2016.02.004
Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome
Abstract
Background: The purpose of this study was to determine the association of the extent of metastatic lymph node involvement with survival in pancreatic cancer.
Methods: This is a retrospective review of a prospectively maintained database of patients who underwent resection for pancreatic adenocarcinoma, 1999-2011.
Results: 165 patients were identified and divided into 3 groups based on the number of positive lymph nodes - 0 (group A), 1-2 (B), >3 (C). Each group had 55 patients. Those in group C were more likely to have a higher T stage, poorly differentiated grade, lymphovascular invasion (LVI), higher mean intraoperative blood loss, positive margins, tumor location involving the uncinate process, and a higher likelihood of undergoing a pancreaticoduodenectomy. Median overall survival (OS) for group A, B and C was 25.5 months (mo), 21 mo and 12.3 mo, respectively (p < 0.001). No survival difference was noted for survival between groups A and B (p = 0.86). The ratio of involved lymph nodes <0.2 was predictive of improved survival (p < 0.001).
Conclusions: Resected pancreatic cancer patients with only 1-2 positive lymph nodes or less than 20% involvement have a similar prognosis to patients without nodal disease. Current staging should consider stratification based on the extent of nodal involvement.
Copyright © 2016. Published by Elsevier Ltd.
Figures



References
-
- Fortner J.G. Regional resection of cancer of the pancreas: a new surgical approach. Surgery (USA) 1973;73:307–320. - PubMed
-
- Pedrazzoli S., DiCarlo V., Dionigi R., Mosca F., Pederzoli P., Pasquali C. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Ann Surg. 1998;228:508–517. - PMC - PubMed
-
- Winter J.M., Cameron J.L., Campbell K.A., Arnold M.A., Chang D.C., Coleman J. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199–1211. - PubMed
-
- Allema J.H., Reinders M.E., Van Gulik T.M., Koelemay M.J.W., Van Leeuwen D.J., De Wit L.T. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 1995;75:2069–2076. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical